Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

TAZAROTENE

TAZAROTENE

Standard Dose
0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TAZAROTENE is listed in Drugs@FDA under application 211175 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TAZAROTENE Form and strength CREAM;TOPICAL - 0.1% Sponsor FOUGERA PHARMS INC Submission history Latest submission status date: 2019-01-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview TAZAROTENE is listed in Drugs@FDA under application 211175 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TAZAROTENE Form and strength CREAM;TOPICAL - 0.1% Sponsor FOUGERA PHARMS INC Submission history Latest submission status date: 2019-01-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.